Navigation Links
New Cancer Therapy in Clinical Trial

The research, published in the July issue of the journal Cancer Cell, published by Cell Press, provides a pharmacological method for enhancing the potency and effectiveness of a tumor necrosis factor (TNF) death receptor ligand against a variety of human cancers.

A new study identifies a combination therapy that may sensitize human cancer cells to a promising treatment currently being used in clinical trials.

Potency and lack of toxicity to normal tissues make activation of TNF-a-related apoptosis-inducing ligand (TRAIL) death receptor signaling an attractive and exciting target for cancer therapy, and it is currently being tested in clinical trials.

However, most cancer cells have defects in their ability to die via a cell death pathway called apoptosis, and unfortunately, TRAIL therapy is not effective in cells that have certain defects in apoptotic pathways.

Dr. Wafik S. El-Deiry from the University of Pennsylvania School of Medicine and colleagues designed a series of studies to gain a better understanding of TRAIL-associated cell signaling pathways in cancer cells and to look for ways to pharmacologically optimize TRAIL therapy.

Dr. El-Deirys group had previously established that c-Myc is a key mediator of TRAIL-induced apoptosis and that cancer cells lacking c-Myc and a functional apoptotic pathway were resistant to TRAIL.

In the current study, the researchers demonstrated that expression of c-Myc in TRAIL-resistant human colon cancer cells sensitized the cells to TRAIL, even when the cells had intrinsic apoptotic defects. The researchers observed that TRAIL induced expression of two potent antiapoptotic molecules, Mcl-1 and cIAP2, and that c-Myc repressed both molecules.

The researchers also discovered that the multikinase inhibitor sorafenib prevented TRAIL-mediated induction of Mcl-1 and cIAP2, and although it had little effect on the killing of TRAIL-resistant c
'"/>




Page: 1 2

Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Cancer Therapy Clinical Trial

(Date:5/29/2015)... To compile the list, the Becker's Hospital ... several awards for clinical and general excellence. The team ... to them in terms of overall excellence, and those ... 50 Great Health Systems to Know 2015 list includes ... Fla.) , Advocate Health Care (Downers Grove, Ill.) , ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 ... recently partnered with Stratus Video Interpreting ... will facilitate better communication and timely care ... and hearing loss. Stratus’ video remote interpreting ... translators, enabling staff to quickly access qualified ...
(Date:5/29/2015)... 29, 2015 The campaign focuses on ... a number of specific concerns within, including the importance ... mental health in the workplace. We are encouraged to ... campaign also brings special focus to people living with ... up and seek help from healthcare professionals and their ...
(Date:5/29/2015)... Oaksterdam University, the first cannabis college in America, will return to ... highly demanded Basic and Advanced Classic Seminars on ... pm each day. Certification is available upon completion of the seminars ... June 14 from 12:00 pm to 6:00 pm. Both the seminars ... & Casino in downtown Las Vegas. , Seminar topics ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 Healthpointe clinics ... injuries with the help of their licensed clinical psychologist, ... brain injuries can lead to an extensive array of ... effects can arise at any time after a traumatic ... caused by any bump or jolt to the head ...
Breaking Medicine News(10 mins):Health News:Becker's Hospital Review Names 50 Great Health Systems to Know 2Health News:Becker's Hospital Review Names 50 Great Health Systems to Know 3Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 2Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 3Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 4Health News:Mediaplanet Brings Activism to Those Living with Mental Illness in Bew “Mental Health Awareness” Campaign 2Health News:Oaksterdam University to Host Educational Cannabis Seminars and Job Fair in Las Vegas June 12 to 15; Training For Those Wanting To Work in Legal Cannabis Industry 2Health News:Oaksterdam University to Host Educational Cannabis Seminars and Job Fair in Las Vegas June 12 to 15; Training For Those Wanting To Work in Legal Cannabis Industry 3Health News:Healthpointe’s Los Angeles County Clinics Are Now Offering Treatment for Mild Traumatic Brain Injuries 2
... bioGUNE and led by Dr. Aitor Hierro, have opened ... of neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS), ... of the National Academy of Sciences of the ... possibility of research in humans to detect this pathology ...
... July 26, 2010 The Marilyn B. Gula Mountains ... cancer with a $50,000 donation to the Phoenix-based Translational ... two years of $300,000. In addition, the Mountains ... Ohio,s University Hospitals (UH) Ireland Cancer Center, bringing the ...
... undergo cardiopulmonary bypass (CPB) during surgery for less ... suffer any impairments in neurocognitive abilities, such as ... Researchers from The Children,s Hospital of Philadelphia, in ... Pediatrics , reported on neuropsychological effects after surgery ...
... School of Medicine have discovered that a kind of ... but not found in humans provokes a strong immune ... chronic inflammation is a major issue. This non-human ... drugs, and may be limiting or undermining their therapeutic ...
... HealthDay Reporter , FRIDAY, July 23 (HealthDay News) -- As ... Americans with Disabilities Act on Monday, a new survey finds ... the quality of life for people with disabilities. Many ... Americans with disabilities and those without, according to a survey ...
... may be reduced if a gene that regulates cancer cell ... University of Illinois at Chicago. Oral cancer is an ... professor in the UIC Center for Molecular Biology of Oral ... 90 percent of oral cancers are squamous cell carcinomas that ...
Cached Medicine News:Health News:New approach which can help to predict neurodegenerative diseases 2Health News:New approach which can help to predict neurodegenerative diseases 3Health News:The Marilyn B. Gula Mountains of Hope Foundation donates additional research funds to TGen 2Health News:Heart bypass for uncomplicated heart surgery does not reduce neurocognitive function in children 2Health News:Non-human sugar in biotech drugs causes inflammation 2Health News:Non-human sugar in biotech drugs causes inflammation 3Health News:Americans With Disabilities Act Reaches 20th Anniversary 2Health News:Americans With Disabilities Act Reaches 20th Anniversary 3Health News:Americans With Disabilities Act Reaches 20th Anniversary 4Health News:Gene may hold key to reducing spread of oral cancers 2
(Date:5/29/2015)... NEW BRUNSWICK, N.J. , May 29, 2015 /PRNewswire-USNewswire/ ... biotech start-up companies originally funded with investments from Foundation ... their research at Bio International 2015 as part of ... the Conference, announced FVCG President James M. Golubieski ... event for the biotechnology industry, will be held in ...
(Date:5/29/2015)... May 29, 2015  The annual customer satisfaction survey ... Praxis EMR as #1 across all specialties. Every year, ... LLC conducts a poll of EHR users and publishes ...   Praxis EMR topped 348 other ... performance based criteria used by Black Book. In addition ...
(Date:5/29/2015)... ON , May 29, 2015 /CNW/ - Covalon ... an advanced medical technologies company, is delighted to ... ended March 31, 2015, which includes revenue for ... the quarter of $264,340. Revenue from advanced wound care ... March 31, 2015 increased 24% to $1,742,672 compared ...
Breaking Medicine Technology:Foundation Venture Capital Group Portfolio Companies to be Highlighted at Bio International in June 2Foundation Venture Capital Group Portfolio Companies to be Highlighted at Bio International in June 3Praxis EMR Ranks #1 for Physician Satisfaction in Black Book's 2015 Survey of Solo and Small Practices 2Covalon Announces Strong Second Quarter Results 2Covalon Announces Strong Second Quarter Results 3
... , , VIENNA, July 15 This week, ... latest advances in research on treatments, risk factors, diagnosis and causes ... -- at the Alzheimer,s Association 2009 International Conference on Alzheimer,s Disease ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090529/ICADLOGO ) , ...
... , NEW YORK, July 14 Keryx Biopharmaceuticals, ... of a Phase 1 clinical study to evaluate KRX-0401 (perifosine) ... pediatric patients. This Phase 1 study is now open for ... Oren Becher, MD, Instructor, Department of Pediatrics, in coordination ...
Cached Medicine Technology:Results From Drug Trials and New Risk Factors Announced at International Alzheimer's Conference 2Results From Drug Trials and New Risk Factors Announced at International Alzheimer's Conference 3Results From Drug Trials and New Risk Factors Announced at International Alzheimer's Conference 4Results From Drug Trials and New Risk Factors Announced at International Alzheimer's Conference 5Results From Drug Trials and New Risk Factors Announced at International Alzheimer's Conference 6Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center 2Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center 3Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center 4
... Relief Padding&trade is perfect for use for ... splinting materials or used to line braces, ... insulates against shock and vibration and conforms ... shearing and chaffing. It is a 2mm ...
Designed to provide relief from chronic or acute back pain by unloading pressure off the lumbar discs and shifting pressure to the abdominal region...
... a modular functional lumbar support for ... the lumbosacral transition. Its modular design ... individually adaptable multi-stage regimen.,Stage 1 (Stabilization ... stabilization of vertebral body segments S1 ...
... hip abduction brace is a lightweight patient friendly ... the Genesis Joint. The Escort provides patients ... don and doff. Superior comfort and improved ... , ,The Escort Hip brace is ...
Medicine Products: